These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis. Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114 [TBL] [Abstract][Full Text] [Related]
3. Microbiology. TB--a new target, a new drug. Cole ST; Alzari PM Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490 [No Abstract] [Full Text] [Related]
4. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164 [TBL] [Abstract][Full Text] [Related]
5. Shortening the treatment of tuberculosis. Mitchison DA Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148 [No Abstract] [Full Text] [Related]
7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
8. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase. Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243 [TBL] [Abstract][Full Text] [Related]
9. Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase. Zhu N; Lin Y; Li D; Gao N; Liu C; You X; Jiang J; Jiang W; Si S J Antimicrob Chemother; 2015 Aug; 70(8):2287-94. PubMed ID: 25957580 [TBL] [Abstract][Full Text] [Related]
10. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase. Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857 [TBL] [Abstract][Full Text] [Related]
11. Identification of inhibitors against Mycobacterium tuberculosis thiamin phosphate synthase, an important target for the development of anti-TB drugs. Khare G; Kar R; Tyagi AK PLoS One; 2011; 6(7):e22441. PubMed ID: 21818324 [TBL] [Abstract][Full Text] [Related]
12. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors. Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832 [TBL] [Abstract][Full Text] [Related]
13. N-Acyl phenothiazines as mycobacterial ATP synthase inhibitors: Rational design, synthesis and in vitro evaluation against drug sensitive, RR and MDR-TB. Reddyrajula R; Perveen S; Negi A; Etikyala U; Manga V; Sharma R; Dalimba UK Bioorg Chem; 2024 Oct; 151():107702. PubMed ID: 39142196 [TBL] [Abstract][Full Text] [Related]
18. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds. Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181 [TBL] [Abstract][Full Text] [Related]
19. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase. Haagsma AC; Podasca I; Koul A; Andries K; Guillemont J; Lill H; Bald D PLoS One; 2011; 6(8):e23575. PubMed ID: 21858172 [TBL] [Abstract][Full Text] [Related]
20. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]